US Broker Ratings

Elanco Animal Health (ELAN) Stock Analysis: Unpacking a 12% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) is drawing attention from the investment community with a calculated potential upside of 12.11%, according to analyst ratings. With its headquarters in Greenfield, Indiana,..

Investor Outlook: Bruker Corporation (BRKR) Shows Promising 11.42% Upside Potential Amid Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR), a leading player in the healthcare sector, stands at an intriguing juncture for investors seeking opportunities in the medical devices industry. With a market capitalization of..

Teleflex Incorporated (TFX) Stock Analysis: Evaluating Growth Potential with an 8.29% Upside

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, continues to attract attention for its unique position in the medical instruments and supplies industry. With a diverse portfolio..

BioNTech SE (BNTX) Stock Analysis: Navigating a Potential 49.82% Upside in the Biotech Arena

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been making headlines with its innovative approaches to treating cancer and infectious diseases. Based in Mainz, Germany, this..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Gem with 172% Potential Upside

Telix Pharmaceuticals Limited (NASDAQ: TLX), a prominent player in the biotechnology industry, has been making waves with its innovative approaches to cancer treatment. Headquartered in North Melbourne, Australia, this commercial-stage..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking a Potential 39% Upside in Healthcare Innovation

Stevanato Group S.p.A. (STVN), a formidable player in the medical instruments and supplies industry, is strategically positioned in the healthcare sector with a market cap of $5.6 billion. Headquartered in..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 27.55% Upside Potential Beckons Investors

Investors on the lookout for promising opportunities in the biotechnology sector should turn their attention to Jazz Pharmaceuticals plc (NASDAQ: JAZZ). With a market capitalization of $10.15 billion, this Dublin-based..

Quest Diagnostics (DGX) Stock Analysis: 12.5% Upside Potential Amid Strong Revenue Growth

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, particularly within the Diagnostics & Research industry. With a substantial market capitalization of $19.69 billion, the..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Exploring an 18.97% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a Japanese pharmaceutical giant with a rich history dating back to 1781, stands as a stalwart in the global healthcare sector. With a market..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a Promising 12.84% Upside Potential

For investors seeking opportunities in the biotech sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) offers an intriguing proposition. With a market capitalization of $7.92 billion, the company is a prominent player..

Teva Pharmaceutical Industries (TEVA): Investor Outlook on a Promising 7.98% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a heavyweight in the healthcare sector, has been a compelling name in the pharmaceutical landscape. Specializing in the development, manufacturing, and distribution of generic..

Genmab A/S (GMAB) Stock Analysis: A Lucrative 16.78% Upside Awaits Investors

Genmab A/S (NASDAQ: GMAB) is drawing significant attention in the biotechnology sector, offering a promising potential upside of 16.78% according to current analyst targets. Based in Copenhagen, Denmark, this biotech..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the 18.84% Potential Upside with Strong Buy Ratings

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is capturing investor attention with its robust market presence in the diagnostics and research industry. With a market capitalization..

Royalty Pharma (RPRX) Stock Analysis: Unlocking Nearly 20% Upside with Robust Buy Ratings

For investors with an eye on the biotechnology sector, Royalty Pharma plc (NASDAQ: RPRX) presents an intriguing opportunity, promising nearly 20% upside potential. As a distinctive player in the healthcare..

United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating the Growth Potential in the Biotech Sector

United Therapeutics Corporation (NASDAQ: UTHR), with its robust pipeline and innovative focus on combating chronic and life-threatening diseases, stands as a significant player in the healthcare sector, specifically within the..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 32.98% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, particularly in the medical instruments and supplies industry, offers intriguing prospects for investors seeking both growth and stability. With..

Bristol-Myers Squibb (BMY) Investor Outlook: Strong Dividend Yield and Strategic Pipeline in Focus

Bristol-Myers Squibb Company (BMY), a leading player in the healthcare sector, continues to attract investor attention with its robust dividend yield and a promising pipeline of biopharmaceutical products. With a..

Doximity, Inc. (DOCS) Stock Analysis: Potential 55% Upside Amid Robust Revenue Growth

Doximity, Inc. (NYSE: DOCS), a leader in digital health information services, is positioning itself as a compelling investment opportunity within the healthcare sector. With a market capitalization of $8.22 billion,..

HealthEquity, Inc. (HQY) Investor Outlook: A 26.84% Upside Potential Awaits

As the healthcare sector continues to evolve, HealthEquity, Inc. (NASDAQ: HQY) stands out as a key player with a promising forecast. With a market capitalization of $8.26 billion, HealthEquity is..

Grifols, S.A. (GRFS) Valuation Insights: Exploring a Potential 23% Upside for Investors

As a significant player in the healthcare sector, Grifols, S.A. (GRFS) is known for its robust portfolio of plasma-derived therapies and diagnostic solutions. With its operations extending across Spain, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds